Literature DB >> 1520762

Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment.

Y C Chuang1, C Y Yuan, C Y Liu, C K Lan, A H Huang.   

Abstract

From May 1985 through July 1990, 28 episodes of Vibrio vulnificus infection in 27 patients were encountered in five major hospitals in Taiwan. The ages of patients ranged from 19 to 76 years; the ratio of male to female patients was 2:1. Eighteen episodes manifested as bacteremia and eight as wound infections alone. One patient each developed gastroenteritis and pneumonia after nearly drowning. Twenty-three patients exhibited skin manifestations. Twenty patients had underlying diseases. All patients were treated with antibiotics, and 14 also underwent some form of surgical treatment (incision and drainage, fasciotomy, debridement, or amputation). Thirteen of the 28 episodes were preceded by precipitating factors; most were due to ingestion of seafood or exposure of abraded skin to salt water. Ten of the 18 septicemic patients died--most within 48 hours of hospitalization. One patient without bacteremia who had a wound infection died. Results of in vitro susceptibility studies suggested that ampicillin or a third-generation cephalosporin would be effective. Susceptibility to aminoglycosides was observed for greater than 90% of isolates. We recommend combined therapy with a third-generation cephalosporin or ampicillin and an aminoglycoside along with appropriate surgical therapy for the treatment of V. vulnificus infection.

Entities:  

Mesh:

Year:  1992        PMID: 1520762     DOI: 10.1093/clinids/15.2.271

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

1.  Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin.

Authors:  J J Fan; C P Shao; Y C Ho; C K Yu; L I Hor
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Necrotising fasciitis caused by Vibrio vulnificus in a child without known risk factors.

Authors:  Shun Chiu; Cheng-Hsum Chiu; Tang-Her Jaing; Kao-Jung Chang; Tzou-Yien Lin
Journal:  Eur J Pediatr       Date:  2002-08       Impact factor: 3.183

3.  Cloning and sequence analysis of a novel hemolysin gene (vllY) from Vibrio vulnificus.

Authors:  T M Chang; Y C Chuang; J H Su; M C Chang
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

4.  Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention.

Authors:  Y-L Kuo; S-J Shieh; H-Y Chiu; J-W Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

Review 5.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

6.  In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.

Authors:  Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

7.  Biliary tract infection caused by Vibrio fluvialis in an immunocompromised patient.

Authors:  W-L Liu; Y-H Chiu; C-M Chao; C-C Hou; C-C Lai
Journal:  Infection       Date:  2011-06-28       Impact factor: 3.553

8.  Two cases of severe sepsis due to Vibrio vulnificus wound infection acquired in the Baltic Sea.

Authors:  J Ruppert; B Panzig; L Guertler; P Hinz; G Schwesinger; S B Felix; S Friesecke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

9.  Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection.

Authors:  Y C Chuang; W C Ko; S T Wang; J W Liu; C F Kuo; J J Wu; K Y Huang
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  Comparative genome analysis of Vibrio vulnificus, a marine pathogen.

Authors:  Chung-Yung Chen; Keh-Ming Wu; Yo-Cheng Chang; Chuan-Hsiung Chang; Hui-Chi Tsai; Tsai-Lien Liao; Yen-Ming Liu; Hsiang-Ju Chen; Arthur Bo-Ting Shen; Jian-Chiuan Li; Teh-Li Su; Chung-Ping Shao; Chung-Te Lee; Lien-I Hor; Shih-Feng Tsai
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.